Completed PHASE1 INTERVENTIONAL 1-arm NCT00948987

Mechanism Based Resistance to Aspirin

Sponsor: Bayer

Conditions Aspirin Resistance Pharmacological Aspirin Non-responsiveness

Interventions Aspirin

Updated 5 times since 2017 Last updated: Oct 14, 2009 Started: Sep 30, 2004 Primary completion: Oct 31, 2009 Completion: Oct 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Aspirin Resistance and Pharmacological Aspirin Non-responsiveness and is currently completed. Bayer leads this study, which shows 5 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Sep 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bayer
National Institutes of Health (NIH)
University of Pennsylvania

Data source: University of Pennsylvania

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.